Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearching for Mounjaro through sites like mounjaro market.com reflects a genuinely understandable impulse: the medicine works, NHS waiting lists are long, and private prices can feel steep. The trial evidence is real. In SURMOUNT-1, published in the New England Journal of Medicine, tirzepatide produced an average body-weight reduction of around 20–21% over 72 weeks at the highest dose — findings that have driven enormous demand. The thing to know before you reach for an unfamiliar website is that Mounjaro is a Prescription-Only Medicine in the UK: a prescriber must assess whether it is clinically appropriate for you before any supply can legally take place, and the source of that supply matters considerably for your safety.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Our "Mounjaro market" explainer covers what these domain names typically are, and the answer is that most are not pharmacies at all. Some are marketplace aggregators listing prices from various sellers; others are grey-market or international supply routes; a few are outright counterfeit operations using professional-looking branding. The common thread is that none of them sits within the UK's licensed supply chain, and most bypass the clinical assessment that the law requires.
Tirzepatide's mechanism (activating both GIP and GLP-1 receptors to reduce appetite and slow gastric emptying) is what makes it clinically effective. It is also what makes it unsuitable for some people: a history of pancreatitis, certain gastrointestinal conditions, medullary thyroid carcinoma, or current use of particular medicines can all affect whether a prescriber would consider it appropriate. A marketplace site cannot make that assessment. Our page on the risks of grey-market Mounjaro goes further on what unlicensed supply chains actually look like in practice.
The MHRA has been explicit: in October 2025 investigators raided the first known UK site manufacturing counterfeit tirzepatide pens, having already seized roughly 20 million doses of illegally traded weight-loss medicines across 2025. Some counterfeit pens seized in earlier operations were found to contain insulin rather than the labelled medicine, a potentially life-threatening substitution. The regulator's Yellow Card scheme accepts reports of suspect sellers as well as suspected side effects.
NICE recommended tirzepatide for NHS use in December 2024 (TA1026), phasing eligibility by BMI and the number of weight-related conditions a patient has. From June 2026 the NHS criteria extended to adults with a BMI of 35–39.9 alongside four or more qualifying conditions. Even patients who meet those criteria often face waits, because GP practice participation in the new prescribing contract is optional and capacity varies by area.
Private prescribing operates under the same legal and clinical framework (a prescriber must review the patient and issue a valid prescription) but removes the NHS eligibility thresholds and waiting times. The private licensed route is what a GPhC-registered online pharmacy provides. You can read the NICE tirzepatide appraisal (TA1026) directly if you want the full eligibility picture, or our Mounjaro overview summarises what it means for private patients. For anyone who has already looked at costs, our Mounjaro pricing page explains what a legitimate private price actually includes.
Lower BMI thresholds apply for some ethnic backgrounds under UK guidance, and BMI alone is never the whole story, a prescriber weighs your full clinical picture. That is not bureaucracy; it is what makes the medicine safe.
The GPhC is the regulator for pharmacies operating in Great Britain. Every legitimate online pharmacy dispensing Prescription-Only Medicines to UK patients must be registered with it, and that registration is publicly searchable. It takes about thirty seconds: go to the GPhC register, enter the pharmacy's name or registration number, and the result is definitive. If a seller does not appear there, or declines to provide a registration number, that is the answer.
Other patterns the MHRA asks patients to watch for: sellers who dispatch Mounjaro without asking you to complete a health questionnaire reviewed by a prescriber; prices that sit well below the typical private market range (Eli Lilly raised UK list prices substantially from September 2025, and legitimate private prices reflect that); and any mention of discount codes or promotional offers attached to a Prescription-Only Medicine. If you are trying to compare the market for Mounjaro, our dedicated page explains what a meaningful comparison actually involves and why headline price alone can be misleading. Our page on tirzepatide being sold via Telegram describes some of the more brazen channels currently in use.
nume does not exist in this supply chain. At our pharmacy, GPhC registration number 9012878, every consultation is reviewed by a named GPhC-registered Independent Prescriber the same day, a real clinician reading your answers, not a form being auto-processed. Medicines are sourced through authorised UK supply only.
If you have already received Mounjaro (or what was sold as Mounjaro) from a site you cannot now verify on the GPhC register, the sensible steps are straightforward. Stop using the product. Contact your GP or a pharmacist who can review what you have. Report the seller to the MHRA via the Yellow Card portal, which accepts reports from patients and is the fastest route to regulatory action.
Do not try to verify the medicine's authenticity yourself, counterfeit pens are often visually indistinguishable from genuine ones. The concern is not only about what is printed on the label; it is about what is inside the cartridge.
If you want to explore treatment through a proper clinical route, our free consultation is the starting point. There is no obligation, and checking your eligibility costs nothing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.